STEVANATO GROUP SPA O.N. (87N) - Total Liabilities

Latest as of December 2025: €1.06 Billion EUR ≈ $1.24 Billion USD

Based on the latest financial reports, STEVANATO GROUP SPA O.N. (87N) has total liabilities worth €1.06 Billion EUR (≈ $1.24 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore STEVANATO GROUP SPA O.N. (87N) cash conversion ratio to assess how effectively this company generates cash.

STEVANATO GROUP SPA O.N. - Total Liabilities Trend (2021–2025)

This chart illustrates how STEVANATO GROUP SPA O.N.'s total liabilities have evolved over time, based on quarterly financial data. Check STEVANATO GROUP SPA O.N. liquid asset ratio to evaluate the company's liquid asset resilience ratio.

STEVANATO GROUP SPA O.N. Competitors by Total Liabilities

The table below lists competitors of STEVANATO GROUP SPA O.N. ranked by their total liabilities.

Company Country Total Liabilities
Guangzhou KingTeller Technology Co Ltd
SHE:002177
China CN¥25.84 Million
VITZROCELL Co.Ltd
KQ:082920
Korea ₩36.50 Billion
Drägerwerk AG & Co. KGaA
XETRA:DRW8
Germany €1.52 Billion
Prima Andalan Mandiri Tbk PT
JK:MCOL
Indonesia Rp158.96 Million
Zhejiang Shengyang Science
SHG:603703
China CN¥1.10 Billion
Shanxi Zhendong Pharmaceutical
SHE:300158
China CN¥882.65 Million
DNA Link Inc
KQ:127120
Korea ₩54.44 Billion
Shinry Technologies Co Ltd Class A
SHE:300745
China CN¥2.11 Billion

Liability Composition Analysis (2021–2025)

This chart breaks down STEVANATO GROUP SPA O.N.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see STEVANATO GROUP SPA O.N. (87N) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.76 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.71 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.42 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how STEVANATO GROUP SPA O.N.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for STEVANATO GROUP SPA O.N. (2021–2025)

The table below shows the annual total liabilities of STEVANATO GROUP SPA O.N. from 2021 to 2025.

Year Total Liabilities Change
2025-12-31 €1.06 Billion
≈ $1.24 Billion
+14.39%
2024-12-31 €924.43 Million
≈ $1.08 Billion
-1.54%
2023-12-31 €938.93 Million
≈ $1.10 Billion
+41.45%
2022-12-31 €663.79 Million
≈ $776.04 Million
+15.00%
2021-12-31 €577.18 Million
≈ $674.79 Million
--

About STEVANATO GROUP SPA O.N.

F:87N Germany Medical Instruments & Supplies
Market Cap
$831.06 Million
€710.85 Million EUR
Market Cap Rank
#9961 Global
#1190 in Germany
Share Price
€14.30
Change (1 day)
+2.88%
52-Week Range
€11.40 - €23.60
All Time High
€32.30
About

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprisi… Read more